|
Post by JHam on Jan 5, 2015 13:26:03 GMT
|
|
|
Post by JHam on Jan 5, 2015 13:27:59 GMT
92% experienced improvement in rate of progression. Wow.
|
|
|
Post by lcd on Jan 5, 2015 13:28:06 GMT
I sold more too so I only have about 20% of what I owned a week ago. It is going to be another interesting morning. Just search $BCLI on twitter and look at all the interest. Everyone is watching this stock right now.
|
|
|
Post by RLC on Jan 5, 2015 13:30:22 GMT
"We are gratified to have the final data from this study and are very encouraged by the results," commented BrainStorm's CEO Tony Fiorino, MD, PhD. "This study not only extends our earlier phase 1/2 findings regarding the safety of NurOwn™, but also provide a consistent and highly promising picture of NurOwn's efficacy. In particular, I would highlight that we observed not only a highly meaningful reduction in ALS progression on mean ALSFRS and FVC, but we saw subjects with prolonged stabilization and even improvements in function, and all this was achieved with just a single dose of NurOwn™.
|
|
|
Post by avtech on Jan 5, 2015 13:32:24 GMT
Based on these results, I will hang on to my "free" shares from Fridays runup for a while...thanks again for bringing this one to my attention JHam.
|
|
|
Post by lcd on Jan 5, 2015 13:36:55 GMT
Those seem like fantastic results (albeit on 11 patients) but the price is steadily falling anyway. Based on some of things I am reading on twitter, it seems like some people bought in not even knowing that the study only had 11 patients and that it was based in Israel and not the US.
|
|
|
Post by RLC on Jan 5, 2015 13:40:20 GMT
Those seem like fantastic results (albeit on 11 patients) but the price is steadily falling anyway. Based on some of things I am reading on twitter, it seems like some people bought in not even knowing that the study only had 11 patients and that it was based in Israel and not the US. IMO, we weren't going to see the $8 level sustained without unexpected news (partnership, excellent funding, new indication announced, etc.). But hopefully these results will set a new, more respectable, floor for BCLI.
|
|
|
Post by JHam on Jan 5, 2015 13:40:49 GMT
I am completely out now at $6.90. I just couldn't resist looking at a 100% profit and knowing that there is a more than 50% chance this will drop after the call. It has happened too many times where I got greedy and had it backfire. No looking back. I more than doubled what I originally put in, which is not too shabby. Looking to get in again if and when it heads down again.
|
|
|
Post by JHam on Jan 5, 2015 13:41:43 GMT
Anyone else disconnected from the call?
|
|
|
Post by RLC on Jan 5, 2015 13:42:49 GMT
I'm still on.
|
|
|
Post by lcd on Jan 5, 2015 13:43:07 GMT
I am on the video call. They are very excited about the results.
|
|
|
Post by JHam on Jan 5, 2015 13:45:02 GMT
I am back on.
|
|
|
Post by JHam on Jan 5, 2015 13:52:44 GMT
Crazy to see the pps down when they are presenting such outstanding data. Clear case of buy the rumor sell the news.
|
|
|
Post by JHam on Jan 5, 2015 13:54:46 GMT
Wow, 9 patients saw not only saw slowing of progression, but halting and even became better than before treatment. Something never seen before in an ALS treatment according to Dr. Karussis.
|
|
|
Post by JHam on Jan 5, 2015 14:15:26 GMT
Wow, did Tony just let the cat of the bag about a potential partner?
|
|
|
Post by lcd on Jan 5, 2015 14:16:17 GMT
I stepped away for just a second and got back in time to hear someone cut him off. What exactly did he say?
|
|
|
Post by brnhut on Jan 5, 2015 14:16:33 GMT
Thank you for this play, JHam! I jumped in on June 7th, 2014, and rode it down for the rest of the year. I almost closed the position in December to grab a tax loss, but decided to wait for the conference call per this board's anticipation of a positive move up with the conference call. Just pulled my full position pre-market @$7.90 for a 40% gain, and will likely put it back in to avoid short term capital gains. Thanks again, BCLI would have been off my radar forever!
|
|
|
Post by RLC on Jan 5, 2015 14:17:27 GMT
Wow, did Tony just let the cat of the bag about a potential partner? That's kind of what I was thinking. He was quieted very quickly...
|
|
|
Post by RLC on Jan 5, 2015 14:28:47 GMT
I stepped away for just a second and got back in time to hear someone cut him off. What exactly did he say? I was brushing my teeth and the call quality (and my laptop speakers) weren't the best quality, but he was asked about discussions with BP about partnering/licensing and he sort of fumbled with his answer, somewhat implying that they are in discussions. I'm not sure if he tried to correct himself or if someone else stepped in but you could tell he said something that the company wished he could take back.
|
|
|
Post by JHam on Jan 5, 2015 14:29:12 GMT
Well that was a pretty exciting call. All of the analysts seemed pretty blown away by the data as did I. I definitely plan to get back in here at some point. Wouldn't be surprised to see this one continue to appreciate in the near term. They have a legit treatment for ALS and are moving along full steam ahead.
|
|